Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Invested Capital (2022 - 2025)

Historic Invested Capital for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $25.8 million.

  • Lucid Diagnostics' Invested Capital rose 30762.07% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 30762.07%. This contributed to the annual value of $5.4 million for FY2024, which is 33327.56% up from last year.
  • Lucid Diagnostics' Invested Capital amounted to $25.8 million in Q3 2025, which was up 30762.07% from $7.9 million recorded in Q2 2025.
  • Lucid Diagnostics' 5-year Invested Capital high stood at $46.5 million for Q1 2022, and its period low was -$5.4 million during Q1 2025.
  • Moreover, its 4-year median value for Invested Capital was $15.1 million (2023), whereas its average is $16.1 million.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 33327.56% in 2024, then crashed by 14520.77% in 2025.
  • Lucid Diagnostics' Invested Capital (Quarter) stood at $23.0 million in 2022, then plummeted by 110.03% to -$2.3 million in 2023, then skyrocketed by 333.28% to $5.4 million in 2024, then soared by 379.22% to $25.8 million in 2025.
  • Its last three reported values are $25.8 million in Q3 2025, $7.9 million for Q2 2025, and -$5.4 million during Q1 2025.